In our study, the higher expression level of NSUN4, NSUN3, and TET2 presented a better prognosis in ccRCC patients, indicating that these three genes might inhibit the progression of ccRCC. This evidence concerns the gene NSUN4 and nonpapillary renal cell carcinoma.